We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$238M
AUM Growth
+$25.7M
Cap. Flow
+$5.05M
Cap. Flow %
2.13%
Top 10 Hldgs %
35.47%
Holding
116
New
16
Increased
25
Reduced
31
Closed
25

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$5.97M
2
TJX icon
TJX Companies
TJX
+$4.98M
3
PFE icon
Pfizer
PFE
+$4.01M
4
CB icon
Chubb
CB
+$2.74M
5
PG icon
Procter & Gamble
PG
+$2.64M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.34M
2
WRB icon
W.R. Berkley
WRB
+$3.36M
3
DLTR icon
Dollar Tree
DLTR
+$3.31M
4
RF icon
Regions Financial
RF
+$2.99M
5
KDP icon
Keurig Dr Pepper
KDP
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 30.3%
2 Financials 12.53%
3 Healthcare 12.28%
4 Consumer Discretionary 9.74%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$290B
$3.35M 1.41%
35,558
+15,469
+77% +$1.43M
KMB icon
27
Kimberly-Clark
KMB
$35.9B
$3.27M 1.38%
26,904
+818
+3% +$98.9K
EMR icon
28
Emerson Electric
EMR
$88.5B
$3.02M 1.27%
31,041
+7,614
+33% +$697K
CTVA icon
29
Corteva
CTVA
$51B
$3M 1.26%
62,699
-343
-0.5% -$16.4K
CRM icon
30
Salesforce
CRM
$162B
$2.94M 1.24%
11,186
-10,711
-49% -$2.42M
ACN icon
31
Accenture
ACN
$109B
$2.74M 1.16%
7,819
-19
-0.2% -$6.13K
DVN icon
32
Devon Energy
DVN
$49.9B
$2.73M 1.15%
60,345
+10,271
+21% +$470K
PG icon
33
Procter & Gamble
PG
$340B
$2.61M 1.1%
+17,832
New +$2.64M
WMT icon
34
Walmart Inc
WMT
$897B
$2.56M 1.08%
48,639
+26,976
+125% +$1.43M
RTX icon
35
RTX Corp
RTX
$302B
$2.51M 1.06%
+29,845
New +$2.36M
META icon
36
Meta Platforms (Facebook)
META
$1.52T
$2.46M 1.04%
6,960
+1,986
+40% +$647K
RSG icon
37
Republic Services
RSG
$65.7B
$2.4M 1.01%
14,580
JNJ icon
38
Johnson & Johnson
JNJ
$631B
$2.4M 1.01%
15,322
JPM icon
39
JPMorgan Chase
JPM
$956B
$2.31M 0.97%
13,585
+6,088
+81% +$923K
CMI icon
40
Cummins
CMI
$87.4B
$2.24M 0.94%
+9,334
New +$2.12M
UPS icon
41
United Parcel Service
UPS
$89.1B
$2.21M 0.93%
14,074
+3,386
+32% +$512K
CAT icon
42
Caterpillar
CAT
$385B
$2.21M 0.93%
7,476
-13
-0.2% -$3.37K
MTB icon
43
M&T Bank
MTB
$36.3B
$1.87M 0.79%
+13,671
New +$1.72M
NKE icon
44
Nike
NKE
$62.5B
$1.87M 0.79%
17,214
-30
-0.2% -$3.22K
EVRG icon
45
Evergy
EVRG
$18.9B
$1.87M 0.79%
+35,778
New +$1.8M
XOM icon
46
ExxonMobil
XOM
$662B
$1.86M 0.78%
18,636
-60
-0.3% -$6.31K
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$1.71M 0.72%
3,589
+19
+0.5% +$8.46K
HUM icon
48
Humana
HUM
$46.3B
$1.67M 0.7%
+3,653
New +$1.8M
PCAR icon
49
PACCAR
PCAR
$69.1B
$1.51M 0.64%
15,504
-29
-0.2% -$2.6K
AZO icon
50
AutoZone
AZO
$50.1B
$1.49M 0.63%
575
+114
+25% +$296K

Similar funds

Stoneridge Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Stoneridge Investment Partners held 116 positions worth $238M, up 12% from $212M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stoneridge Investment Partners's Q4 2023 filing shows 16 new, 25 increased, 31 reduced and 25 closed positions. Its largest new stake was Biogen: 24,322 shares worth $6.29M. The largest sale was CVS Health, an estimated $6.34M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • Stoneridge Investment Partners's largest Q4 2023 buy was Biogen: 24,322 shares worth $6.29M.
  • Stoneridge Investment Partners added most to Pfizer in Q4 2023, an estimated $4.01M increase.
  • Stoneridge Investment Partners's biggest Q4 2023 reduction was Salesforce, cutting an estimated $2.42M.
  • Stoneridge Investment Partners fully exited CVS Health in Q4 2023, selling an estimated $6.34M.
  • Stoneridge Investment Partners's ten largest holdings make up 35% of its $238M portfolio in Q4 2023.
  • Stoneridge Investment Partners opened 16 new positions and closed 25 in Q4 2023.
  • Stoneridge Investment Partners's portfolio value rose 12% quarter-over-quarter to $238M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.